The current status of digitalis therapy.
D000367:Age Factors; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D002118:Calcium / Q000097:blood; D002648:Child; D003325:Coronary Care Units; D004071:Digitalis Glycosides / Q000008:administration & dosage / Q000494:pharmacology / Q000506:poisoning / Q000627:therapeutic use* / Q000633:toxicity; D004077:Digoxin / Q000008:administration & dosage; D004554:Electric Countershock / Q000009:adverse effects; D004562:Electrocardiography; D004700:Endocrine System Diseases / Q000150:complications; D006331:Heart Diseases / Q000150:complications; D006333:Heart Failure / Q000188:drug therapy; D006339:Heart Rate / Q000187:drug effects; D006349:Heart Valve Diseases / Q000188:drug therapy; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications; D008107:Liver Diseases / Q000150:complications; D008171:Lung Diseases / Q000150:complications; D008274:Magnesium / Q000097:blood; D009765:Obesity / Q000150:complications; D010042:Ouabain / Q000008:administration & dosage; D011041:Poisoning / Q000628:therapy; D011188:Potassium / Q000097:blood; D011602:Psychophysiologic Disorders / Q000150:complications; D011660:Pulmonary Heart Disease / Q000188:drug therapy; D013959:Thyroid Diseases / Q000150:complications; D013997:Time Factors
D004071:Digitalis Glycosides; D010042:Ouabain; D004077:Digoxin; D008274:Magnesium; D011188:Potassium; D002118:Calcium